| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-18 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |